Heparin vs pentasaccharide
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 198 participantsVery low
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Heparin showed no clear difference in DVT compared with pentasaccharide (low certainty).
It is very uncertain whether heparin changes adverse events (thrombocytopenia) compared with pentasaccharide (very low certainty).
Higher‐dose heparin showed no clear difference in major bleeding compared with standard‐dose heparin (low certainty).
Combined mechanical and pharmacological prophylaxis may leads to lower VTE compared with mechanical prophylaxis alone (low certainty).
The review found no eligible studies for this question.
Combined mechanical and pharmacological prophylaxis may leads to lower DVT compared with mechanical prophylaxis alone (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether higher‐dose heparin changes PE compared with standard‐dose heparin (very low certainty).
It is very uncertain whether higher‐dose heparin changes DVT compared with standard‐dose heparin (very low certainty).
It is very uncertain whether higher‐dose heparin changes adverse events (thrombocytopenia) compared with standard‐dose heparin (very low certainty).
Heparin showed no clear difference in VTE compared with pentasaccharide (low certainty).
It is very uncertain whether heparin changes major bleeding compared with pentasaccharide (very low certainty).
Herbal mouthrinse showed no clear difference in presence of dry socket compared with chlorhexidine 0.2% mouthrinse; GRADE not reported.